Arrakis reels in $75 million to drug RNA with small molecules

Thursday, April 18, 2019 - 06:10 in Biology & Nature

The start-up will use its series B financing to build a pipeline of cancer drug candidates taking aim at traditionally undruggable targets like Myc

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net